Research
Dr Ken Ip is actively involved in clinical research to continue the advancement of treatments to patients with skin cancers and dermatological conditions. He oversees multiple clinical trials at present, recruiting participants with:
Severe alopecia areata (>50% hair loss)
Hidradenitis suppurativa
Bullous pemphigoid
Pemphigus vulgaris
Cutaneous lupus erythematosus
In addition to clinical trials, Dr Ken Ip is actively involved in medical education and the training of New Zealand’s future Dermatologists. He is an Honorary Senior Clinical Lecturer at the University of Auckland, and sits on the Board of Trustees for DermNet, the world’s most frequented website for skin diseases.
He has published widely across leading Dermatology journals, and his research in melanoma has been awarded multiple honours and accolades.
Publications
Hall S, Chew CY, Kovitwanichkanont T, Ip K, Cahill J, Gin A, McLean CA, Gin D. Subcorneal pustular dermatosis induced by dupilumab: A novel case. Australas J Dermatol. 2024;65(1):74-76.
Ip K, Li A. Clinical features, histology, and treatment outcomes of granular parakeratosis: a systematic review. Int J Dermatol. 2022;61(8):973-978.
Ip K, Agnew K, Cranshaw I, Ng A, Chandran A. Impact of a see-and-treat melanoma clinic on patient experience. J Dermatolog Treat. 2022;33(4):2021-2023.
Ip K, McKerrow K. Itraconazole in the treatment of basal cell carcinoma: A case-based review of the literature. Australas J Dermatol. 2021;62(3):394-397.
Ip K, Chan BCY. How We Do It: Color-Coded Patient Labels for Enhanced Surgical Instrument Identification During Mohs Micrographic Surgery. Dermatol Surg. 2021;47(8):1122-1123.
Chan BC, Ip K. Illustrating skin thickness with textbook pages to aid suture needle selection. J Am Acad Dermatol. 2021;S0190-9622(21)02205-2.
Ip K, Cheng HS, Oliver FG. Rupioid Psoriasis. JAMA Dermatol. 2021;157(7):859.
Ip K, Chan BCY. Where Is 12 o'Clock? A Survey of Skin Surgical Specimen Orientation Among Dermatologists. Dermatol Surg. 2021;47(7):1009-1010.
Ip K, Koch K, Lamont D. Cutaneous amyloidoma secondary to repeated insulin injections. Postgrad Med J. 2021;97(1149):474.
Ip K, Chandran A, Cranshaw I, Ng A, Giles A, Agnew K. Multidisciplinary Pigmented Lesion Clinic at Auckland District Health Board: impacts on melanoma diagnosis and treatment outcomes. N Z Med J. 2021;134(1530):30-37.
Ip K, Koch K, Lamont D. Granulomatosis with polyangiitis: a life-threatening cause of granulomatous mastitis. ANZ J Surg. 2021;91(1-2):E59-E60.
Ip K, Koch K, Lamont D. Blaschko Linear Acquired Inflammatory Skin Eruption (BLAISE) presenting as a paraneoplastic phenomenon. Int J Dermatol. 2020;59(10):e373-e374.
Elwood JM, Kim SJ, Ip K, Oakley A, Rademaker M. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study. Australas J Dermatol. 2019;60(1):38-44.
Ip , Hartley L, Solanki K, White D. Retention on anti-tumour necrosis factor therapy: the Waikato experience. NZ Med J. 2015;128(1415):34-40.
Awards
Peter Gould Memorial Travel Scholarship: NZ Dermatological Society, 2022
Global Education Award: International Society of Dermatology, 2021
Turnbull Hodge Award: NZ Dermatological Society, 2021
Senior Scholar Award: University of Auckland, 2015
Butland Prize: University of Auckland, 2014
First in Course Award MBChB 551: University of Auckland, 2014
Ellis Dick Prize in Surgery: University of Auckland, 2014
University of Auckland Prize in Clinical Pharmacology & Therapeutics: University of Auckland, 2013
University of Auckland Scholarship: University of Auckland, 2009 - 2011